The better-than-nothing idea: debating the use of placebo controls

March 2002
CMAJ: Canadian Medical Association Journal;3/5/2002, Vol. 166 Issue 5, p573
Academic Journal
Editorial. Comments on the debate over the use of placebo in randomized controlled trials. Arguments that support each side of the conflict between goal-based and duty-based thinking; View that patient consent is an important issue in the debate over medical policy.


Related Articles

  • Does informed consent influence therapeutic outcome? A clinical trial of the hypnotic activity of placebo in patients admitted to hospital. Dahan, R.; Caulin, C.; Figea, L.; Kanis, J.A.; Caulin, F.; Segrestaa, J.M. // British Medical Journal (Clinical Research Edition);8/9/1986, Vol. 293 Issue 6543, p363 

    Examines the impact of written informed consent on the results of clinical trial. Effect of placebo administered to patients with or without consent; Disadvantages inherent in acquiring informed consent; Concerns on the alteration of the outcome of the clinical trial.

  • Expanding the Reach of Clinical Trials. Carroll-Johnson, Rose Mary // Oncology Nursing Forum;Sep2000, Vol. 27 Issue 8, p1197 

    Editorial. Discusses progress being made in clinical trials. Involvement of cancer patients in clinical trials; Ethical aspects of patient care in regard to informed consent, truth telling and placebo use during a clinical trial.

  • How to Make Consent Informed: Possible Lessons from Tibet. Miller, Suellen; Le, Phuoc V.; Craig, Sienna; Adams, Vincanne; Tudor, Carrie; Varner, Michael // IRB: Ethics & Human Research;Nov2007, Vol. 29 Issue 6, p7 

    The article focuses on the study which aims to develop an informed consent process of Tibetan traditional medicine through a randomized placebo-controlled trial in Lhasa, China. The study reveals a process that enables the U.S. and Tibetan research team in meeting their ethical and logistical...

  • The CIOMS View on the Use of Placebo in Clinical Trials. Idänpään-Heikkilä, Juhana E.; Fluss, Sev // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p23 

    Based on worldwide consultations with experts in science and ethics the revised CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects provide guidance on when the use of placebo as a comparator in clinical research is ethically acceptable. The article...

  • Sham Surgury: An Ethical Analysis. Miller, Franklin G. // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p157 

    Surgical clinical trials have seldom used a "sham" or placebo surgical procedure as a control, owing to ethical concerns. Recently, several ethical commentators have argued that sham surgery is either inherently or presumptively unethical. In this article I contend that these arguments are...

  • Pediatric clinical trials: current scenario in the Asia Pacific region. Saldanha, Lisa Marie; Saumya Nayak; Sng, Adeline; Mei-Ling Long; Schrader, Elisabeth; Rahman, Amanur; Lansang, Elvira Zenaida; Wai, Karen; Ken Lee // Pediatric Health, Medicine & Therapeutics;2013, Vol. 4, p47 

    Objective: This site survey was conducted to understand the current pediatric clinical trial landscape across countries in the Asia Pacific region, specifically in terms of interest, experience, capabilities, requirements of the ethics committee, patient availability, and overall challenges...

  • When to give the green light to placebo controls.  // IRB Advisor;Sep2009, Vol. 9 Issue 9, p102 

    The article presents several considerations for institutional review boards (IRBs) when considering studies that involve the use of placebo. Study participants should not be those in need of urgent treatment, such as patients with suicidal ideation or functional impairment. Informed consent...

  • Informing participants of allocation to placebo at trial closure: postal survey. Di Blasi, Zelda; Kaptchuk, Ted; Weinman, John; Kleijnen, Jos // BMJ: British Medical Journal (International Edition);12/7/2002, Vol. 325 Issue 7376, p1329 

    Abstract Objectives To assess whether and how investigators of placebo controlled randomised trials inform participants of their treatment allocation at trial closure and to assess barriers to feedback. Design Postal survey with a semistructured questionnaire. Participants All investigators who...

  • The Definition of Placebo in the Informed Consent Forms of Clinical Trials. Hernández, Astrid; Baños, Josep-E.; Llop, Cristina; Farré, Magí // PLoS ONE;Nov2014, Vol. 9 Issue 11, p1 

    Aim: Lack of knowledge concerning the nature of placebo and why it is necessary may influence the participation of patients in clinical trials. The objective of the present study is to review how placebo is described in written information for participants in clinical trials to be evaluated by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics